Abstract:Background: Bone is a rigid organ that provides physical protection and support to vital organs of the body. Bone loss disorders are commonly associated with increased bone marrow adipose tissue. Bone marrow mesenchymal stromal/stem cells (BMSCs) are multipotent progenitors that can differentiate into osteoblasts, adipocytes, and chondrocytes. Cell division cycle 20 (CDC20) is a co-activator of anaphase promoting complex/cyclosome (APC/C), and is required for ubiquitin ligase activity. Our previous study showed that CDC20 promoted the osteogenic commitment of BMSCs and Cdc20 conditional knockout mice suggested a decline in bone mass. In this study, we found that knockdown of CDC20 promoted adipogenic differentiation of BMSCs by modulating β-catenin, which suggested a link between adipogenesis and osteogenesis. Methods: Lentivirus containing a CDC20 shRNA was used for CDC20 knockdown in human BMSCs (hBMSCs). Primary mouse BMSCs (mBMSCs) were isolated from Cdc20f/f and Sp7-Cre;Cdc20f/f mice. Adipogenesis was examined using quantitative real-time reverse transcription PCR (qRT-PCR) and western blotting analysis of adipogenic regulators, Oil Red O staining, and transplantation into nude mice. CDC20 knockout efficiency was determined through immunochemistry, qRT-PCR, and western blotting of bone marrow. Accumulation of adiposity was measured through histology and staining of bone sections. Exploration of the molecular mechanism was determined through western blotting, Oil Red O staining, and qRT-PCR. Results: CDC20 expression in hBMSCs was significantly decreased during adipogenic differentiation. CDC20 knockdown enhanced hBMSC adipogenic differentiation in vitro. CDC20-knockdown hBMSCs showed more adipose tissue-like constructs upon hematoxylin and eosin (H&E) and Oil Red O staining. Sp7-Cre;Cdc20f/f mice presented increased adipocytes in their bone marrow compared with the control mice. mBMSCs from Sp7-Cre;Cdc20f/f mice showed upregulated adipogenic differentiation. Knockdown of CDC20 led to decreased β-catenin levels, and a β-catenin pathway activator (lithium chloride) abolished the role of CDC20 in BMSC adipogenic differentiation. Conclusions: Our findings showed that CDC20 knockdown enhanced adipogenesis of hBMSC and mBMSCs adipogenesis in vitro and in vivo. CDC20 regulates both adipogenesis and osteogenesis of BMSCs, and might lead to the development of new therapeutic targets for "fatty bone" and osteoporosis.

CDC20 Promotes Bone Formation Via APC/C Dependent Ubiquitination and Degradation of P65

Knockdown of CDC20 promotes adipogenesis of bone marrow-derived stem cells by modulating β-catenin

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Cdc42 is Essential for Both Articular Cartilage Degeneration and Subchondral Bone Deterioration in Experimental Osteoarthritis

Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.

Conditional Knockout of Cdc20 Attenuates Osteogenesis in Craniofacial Bones.

Targeting Cdc20 As a Novel Cancer Therapeutic Strategy.

UBE2C orchestrates bone formation through stabilization of SMAD1/5

Inhibition of CDC20 Suppressed the Development and Progression of Mantle Cell Lymphoma

Signaling Cascades Governing Cdc42-Mediated Chondrogenic Differentiation and Mensenchymal Condensation

APC(Cdc20) Suppresses Apoptosis Through Targeting Bim for Ubiquitination and Destruction.

Cell Division Cycle 20 (CDC20) Drives Prostate Cancer Progression Via Stabilization of Β-Catenin in Cancer Stem-Like Cells

CDC20 Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma Through the Wnt/β‑catenin Signaling Pathway.

C-Abl Promotes Osteoblast Expansion by Differentially Regulating Canonical and Non-Canonical BMP Pathways and P16 INK4a Expression

APC<SUP>CDC20</SUP>-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma

Targeted Disruption of PRC1.1 Complex Enhances Bone Remodeling

LMCD1 Promotes Osteogenic Differentiation of Human Bone Marrow Stem Cells by Regulating BMP Signaling

PDCD4 Negatively Regulated Osteogenic Differentiation and Bone Defect Repair of Mesenchymal Stem Cells Through GSK-3β/β-Catenin Pathway

Pdcd4 Negatively Regulated Osteogenic Differentiation And Bone Defect Repair Of Mesenchymal Stem Cells Through Gsk-3 Beta/Beta-Catenin Pathway

Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation

CDC20 Regulates the Cell Proliferation and Radiosensitivity of P53 Mutant HCC Cells Through the Bcl-2/Bax Pathway.